Eldiny™ is pharmacy integrated healthcare payment infrastructure that turns pooled community and institutional support into restricted-use pharmacy credits at the counter, so patients can afford their prescriptions with dignity.

Prescription affordability in the United States is increasingly unstable as medication prices rise and the population ages. More than 10,000 Americans turn 65 each day, many on fixed incomes facing coverage gaps and rising out-of-pocket costs. Each year, hundreds of billions of dollars are spent on prescription drugs and additional assistance programs run by employers, governments, foundations, and community organizations. Much of this support moves through fragmented mechanisms that are hard to manage and hard to use at the moment care is needed.At the same time, U.S. prescription drug spending exceeds $400 billion annually, with billions more directed toward affordability assistance through employers, governments, foundations, and community programs. Coupons, grants, and reimbursement programs often lack interoperability and real-time access. Sponsors have limited transparency into how and when their assistance is used. Patients face complex, uncertain processes at precisely the point when they need a simple “yes” at the pharmacy counter.There is no standardized infrastructure to convert third‑party capital into restricted, auditable prescription payments at scale.
Eldiny brings together community, institutional, and sponsor capital into a unified system so medication support reaches patients at the moment it is needed most.

Eldiny™ is a product of Limmor Group. © 2026 Limmor Group. All rights reserved.
Eldiny is a structured support system for prescriptions. Community and institutional funds are pooled into defined support pools and converted into restricted-use pharmacy credits. When someone cannot afford their medication, those credits are applied in real time at the pharmacy counter to verified prescriptions—ensuring funds are targeted, auditable, and used only for their intended purpose through secure healthcare payment rails.

Eldiny is launching with fixed‑income seniors navigating prescription affordability gaps as our initial deployment. This focus allows us to validate restricted-use pharmacy payments, real time application at the counter, and compliance workflows in a high need, high scrutiny population.
From this foundation, Eldiny will expand to employer sponsored, private sector, union, and government populations, applying the same infrastructure to broader benefit and assistance programs.

Government & Public Agencies
Deploy structured affordability capital through compliant, restricted-use payment infrastructure with real time visibility and auditability.
Employers & Benefit Sponsors
Convert benefit allocations into pharmacy credits applied directly at the point of sale, with clear rules, controls, and reporting.
Foundations & Community Health Initiatives
Ensure assistance funds are applied only to verified prescriptions, with the transparency and governance needed to protect mission and dollars.
Eldiny is led by a founder with executive leadership experience across global financial institutions and New York City government. His career has focused on designing and operating complex institutional systems, providing firsthand insight into how regulatory frameworks, capital flows, and operational infrastructure interact at scale. This background informs Eldiny’s compliance‑first design and institutional deployment strategy, with a focus on real‑world implementation in regulated healthcare and financial environments.
Eldiny aims to become foundational infrastructure for restricted‑use healthcare payments in the United States. By structuring fragmented medication support into a unified, auditable payment system, Eldiny enables patients, pharmacies, and institutions to participate in a more dignified, transparent, and effective model for medication affordability.
We are preparing structured pilot deployments with pharmacies and institutional sponsors. If your organization is exploring compliant medication affordability solutions, we welcome the conversation.